Therefore, we tested the hypothesis that in SS hypertension, the activation of NFκB inflammatory pathway by upregulation of endogenous Ang II/reactive oxygen species (ROS) impairs insulin sensitivity and insulin signaling in the skeletal muscle. This evidence concerns the gene NFKB1 and synovial sarcoma.